I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Ono, Taihei
34
results:
Search for persons
X
Format
Online (34)
Mediatypes
Articles (Online) (22)
Bookchapter (Online) (1)
OpenAccess-fulltext (11)
Sorted by: Relevance
Sorted by: Year
?
1
A Prospective Observational Study of Osimertinib for Chemo-..:
Igawa, Satoshi
;
Kasajima, Masashi
;
Ono, Taihei
...
Cancer Management and Research. 13 (2021) - p. 8695-8705 , 2021
Link:
https://doi.org/10.2147/..
?
2
First-line osimertinib for poor performance status patients..:
Igawa, Satoshi
;
Fukui, Tomoya
;
Kasajima, Masashi
...
Investigational New Drugs. 40 (2021) 2 - p. 430-437 , 2021
Link:
https://doi.org/10.1007/..
?
3
Impact of Amrubicin Monotherapy as Second-Line Chemotherapy..:
Igawa, Satoshi
;
Ono, Taihei
;
Kasajima, Masashi
...
Cancer Management and Research. 12 (2020) - p. 4911-4921 , 2020
Link:
https://doi.org/10.2147/..
?
4
Real-world assessment of afatinib for patients with EGFR-po..:
Igawa, Satoshi
;
Ono, Taihei
;
Kasajima, Masashi
...
Investigational New Drugs. 38 (2020) 6 - p. 1906-1914 , 2020
Link:
https://doi.org/10.1007/..
?
5
Impact of neutrophil-to-lymphocyte ratio in patients with E..:
Ono, Taihei
;
Igawa, Satoshi
;
Kurahayashi, Shintaro
...
Investigational New Drugs. 38 (2020) 3 - p. 885-893 , 2020
Link:
https://doi.org/10.1007/..
?
6
Evaluation of osimertinib efficacy according to body surfac..:
Ono, Taihei
;
Igawa, Satoshi
;
Ozawa, Takahiro
...
Thoracic Cancer. 10 (2019) 4 - p. 880-889 , 2019
Link:
https://doi.org/10.1111/..
?
7
Impact of EGFR genotype on the efficacy of osimertinib in E..:
Igawa, Satoshi
;
Ono, Taihei
;
Kasajima, Masashi
...
Cancer Management and Research. 11 (2019) - p. 4883-4892 , 2019
Link:
https://doi.org/10.2147/..
?
8
Comparison of carboplatin plus etoposide with amrubicin mon..:
Igawa, Satoshi
;
Shirasawa, Masayuki
;
Ozawa, Takahiro
...
Thoracic Cancer. 9 (2018) 8 - p. 967-973 , 2018
Link:
https://doi.org/10.1111/..
?
9
A Prospective Observational Study of Osimertinib for Chemo-..:
Igawa, Satoshi
;
Kasajima, Masashi
;
Ono, Taihei
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612658/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
10
A Prospective Observational Study of Osimertinib for Chemo-..:
Igawa, Satoshi
;
Kasajima, Masashi
;
Ono, Taihei
...
info:eu-repo/semantics/altIdentifier/doi/10.2147/CMAR.S339891. , 2021
Link:
https://www.dovepress.co..
?
11
Impact of Amrubicin Monotherapy as Second-Line Chemotherapy..:
Igawa, Satoshi
;
Ono, Taihei
;
Kasajima, Masashi
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320750/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
12
Impact of Amrubicin Monotherapy as Second-Line Chemotherapy..:
Igawa, Satoshi
;
Ono, Taihei
;
Kasajima, Masashi
...
info:eu-repo/semantics/altIdentifier/doi/10.2147/CMAR.S255552. , 2020
Link:
https://www.dovepress.co..
?
13
Impact of EGFR genotype on the efficacy of osimertinib in E..:
Igawa, Satoshi
;
Ono, Taihei
;
Kasajima, Masashi
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549661/. , 2019
Link:
http://www.ncbi.nlm.nih...
?
14
Evaluation of osimertinib efficacy according to body surfac..:
Ono, Taihei
;
Igawa, Satoshi
;
Ozawa, Takahiro
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590234/. , 2019
Link:
http://www.ncbi.nlm.nih...
?
15
Impact of EGFR genotype on the efficacy of osimertinib in E..:
Igawa, Satoshi
;
Ono, Taihei
;
Kasajima, Masashi
...
info:eu-repo/semantics/altIdentifier/doi/10.2147/CMAR.S207170. , 2019
Link:
https://www.dovepress.co..
1-15
